Found: 38
Select item for more details and to access through your institution.
Serum oncostatin M at baseline predicts mucosal healing in Crohn's disease patients treated with infliximab.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 2, p. 284, doi. 10.1111/apt.15870
- By:
- Publication type:
- Article
Editorial: PNPLA3 genotype and liver diseases–more than non‐alcoholic fatty liver disease. Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 2, p. 391, doi. 10.1111/apt.15873
- By:
- Publication type:
- Article
Editorial: transperineal ultrasound in addition to a transabdominal ultrasound in ulcerative colitis—one more arrow in the quiver of non‐invasive diagnostics. Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 2, p. 403, doi. 10.1111/apt.15871
- By:
- Publication type:
- Article
All‐cause and cause‐specific mortality in microscopic colitis: a Danish nationwide matched cohort study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 2, p. 319, doi. 10.1111/apt.15868
- By:
- Publication type:
- Article
Increasing comorbidities in a South Korea insured population‐based cohort of patients with chronic hepatitis B.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 2, p. 371, doi. 10.1111/apt.15867
- By:
- Publication type:
- Article
Increased risk of permanent stoma in Crohn's disease associated with hidradenitis suppurativa: a case‐control study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 2, p. 303, doi. 10.1111/apt.15863
- By:
- Publication type:
- Article
Editorial: the road to elimination of viral hepatitis–another promising real‐world experience.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 2, p. 405, doi. 10.1111/apt.15837
- By:
- Publication type:
- Article
Real‐world treatment patterns and outcomes using terlipressin in 203 patients with the hepatorenal syndrome.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 2, p. 351, doi. 10.1111/apt.15836
- By:
- Publication type:
- Article
Editorial: simultaneous, prolonged monitoring of the acid pocket and oesophageal reflux. Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 2, p. 398, doi. 10.1111/apt.15835
- By:
- Publication type:
- Article
Letter: assessing iron deficiency in patients with IBD—a step in the right direction, but uncertainty remains.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 2, p. 413, doi. 10.1111/apt.15833
- By:
- Publication type:
- Article
Editorial: diagnostic precision of iron deficiency in inflammatory bowel disease. Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 2, p. 401, doi. 10.1111/apt.15832
- By:
- Publication type:
- Article
Editorial: no man's oesophagus is an island—authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 2, p. 396, doi. 10.1111/apt.15831
- By:
- Publication type:
- Article
Impact of the introduction of direct‐acting anti‐viral drugs on hepatocarcinogenesis: a prospective serial follow‐up MRI study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 2, p. 359, doi. 10.1111/apt.15825
- By:
- Publication type:
- Article
Letter: low population mortality from COVID‐19 in countries south of latitude 35° North supports vitamin D as a factor determining severity. Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 2, p. 412, doi. 10.1111/apt.15823
- By:
- Publication type:
- Article
Editorial: peristomal pyoderma gangrenosum—a challenge for patients, healthcare professionals and research.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 2, p. 404, doi. 10.1111/apt.15822
- By:
- Publication type:
- Article
Frailty is independently associated with mortality in 11 001 patients with inflammatory bowel diseases.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 2, p. 311, doi. 10.1111/apt.15821
- By:
- Publication type:
- Article
Letter: low population mortality from COVID‐19 in countries south of latitude 35 degrees North supports vitamin D as a factor determining severity.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 2, p. 411, doi. 10.1111/apt.15820
- By:
- Publication type:
- Article
Editorial: gut microbiota profile in patients with autoimmune hepatitis—a clue for adjunctive probiotic therapy? Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 2, p. 394, doi. 10.1111/apt.15819
- By:
- Publication type:
- Article
Review article: FODMAPS, prebiotics and gut health‐the FODMAP hypothesis revisited.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 2, p. 233, doi. 10.1111/apt.15818
- By:
- Publication type:
- Article
Letter: does vitamin D have a potential role against COVID‐19? Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 2, p. 410, doi. 10.1111/apt.15817
- By:
- Publication type:
- Article
Editorial: transperineal ultrasound in addition to a transabdominal ultrasound in ulcerative colitis—one more arrow in the quiver of non‐invasive diagnostics.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 2, p. 401, doi. 10.1111/apt.15816
- By:
- Publication type:
- Article
Review article: COVID‐19 and liver disease—what we know on 1st May 2020.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 2, p. 267, doi. 10.1111/apt.15813
- By:
- Publication type:
- Article
Letter: bone fracture risk among older long‐term users of proton pump inhibitors. Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 2, p. 408, doi. 10.1111/apt.15805
- By:
- Publication type:
- Article
A prospective, multicentre study in acute non‐cirrhotic, non‐malignant portal vein thrombosis: comparison of medical and interventional treatment.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 2, p. 329, doi. 10.1111/apt.15811
- By:
- Publication type:
- Article
Editorial: improving precision of iron deficiency diagnosis in inflammatory bowel disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 2, p. 400, doi. 10.1111/apt.15809
- By:
- Publication type:
- Article
Therapeutic thresholds for golimumab serum concentrations during induction and maintenance therapy in ulcerative colitis: results from the GO‐LEVEL study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 2, p. 292, doi. 10.1111/apt.15808
- By:
- Publication type:
- Article
Editorial: simultaneous prolonged monitoring of the acid pocket and oesophageal reflux.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 2, p. 397, doi. 10.1111/apt.15807
- By:
- Publication type:
- Article
Fibrogenesis and inflammation contribute to the pathogenesis of cirrhotic cardiomyopathy.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 2, p. 340, doi. 10.1111/apt.15812
- By:
- Publication type:
- Article
2019 novel coronavirus disease (COVID‐19) in patients with inflammatory bowel diseases.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 2, p. 276, doi. 10.1111/apt.15804
- By:
- Publication type:
- Article
Mortality in adults with chronic hepatitis B infection in the United States: a population‐based study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 2, p. 382, doi. 10.1111/apt.15803
- By:
- Publication type:
- Article
Letter: does vitamin D have a potential role against COVID‐19?
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 2, p. 409, doi. 10.1111/apt.15801
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 2, p. 219, doi. 10.1111/apt.15350
- Publication type:
- Article
Editorial: no man's oesophagus is an island.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 2, p. 395, doi. 10.1111/apt.15799
- By:
- Publication type:
- Article
Editorial: gut microbiota profile in patients with autoimmune hepatitis—a clue for adjunctive probiotic therapy?
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 2, p. 392, doi. 10.1111/apt.15795
- By:
- Publication type:
- Article
Letter: bone fracture risk among older long‐term users of proton pump inhibitors.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 2, p. 407, doi. 10.1111/apt.15763
- By:
- Publication type:
- Article
Review article: bugs, inflammation and mood—a microbiota‐based approach to psychiatric symptoms in inflammatory bowel diseases.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 2, p. 247, doi. 10.1111/apt.15787
- By:
- Publication type:
- Article
Systematic review with meta‐analysis: liver transplant provides survival benefit in patients with acute on chronic liver failure.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 2, p. 222, doi. 10.1111/apt.15793
- By:
- Publication type:
- Article
Editorial: PNPLA3 genotype and liver diseases—more than non‐alcoholic fatty liver disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 2, p. 390, doi. 10.1111/apt.15788
- By:
- Publication type:
- Article